SCM
Stonepine Capital Management Portfolio holdings
AUM
$102M
This Quarter Return
+0.53%
1 Year Return
+40.04%
3 Year Return
+160.28%
5 Year Return
+195.28%
10 Year Return
–
AUM
$241M
AUM Growth
+$241M
(+11%)
Cap. Flow
+$18.8M
Cap. Flow
% of AUM
7.79%
Top 10 Holdings %
Top 10 Hldgs %
74.61%
Holding
31
New
8
Increased
10
Reduced
8
Closed
3
Top Buys
| 1 |
AMRN
Amarin Corp
AMRN
|
$16.2M |
| 2 |
Enanta Pharmaceuticals
ENTA
|
$8.54M |
| 3 |
Ligand Pharmaceuticals
LGND
|
$8.29M |
| 4 |
QuidelOrtho
QDEL
|
$6.95M |
| 5 |
Xeris Biopharma Holdings
XERS
|
$5.81M |
Top Sells
| 1 |
CTIC
CTI BioPharma Corp. (DE) Common Stock
CTIC
|
$19.2M |
| 2 |
Evolus
EOLS
|
$14.3M |
| 3 |
ADMA Biologics
ADMA
|
$5.09M |
| 4 |
Avalo Therapeutics
AVTX
|
$2.57M |
| 5 |
OPTN
OptiNose
OPTN
|
$2.27M |
Sector Composition
| 1 | Healthcare | 94.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
ANI Pharmaceuticals
ANIP
$2.03B
| $733K | 0.3% |
26,060
-26,230
| -50% | -$738K |
|
|
MRNS
27
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $531K | 0.22% |
+56,747
| New | +$531K |
|
28
NeuroOne Medical Technologies
NMTC
$38.2M
| $273K | 0.11% |
248,105
-250,249
| -50% | -$275K |
|
|
CBAY
29
DELISTED
Cymabay Therapeutics
CBAY
| – | – |
-300,000
| Closed | -$1.01M |
|
30
Aldeyra Therapeutics
ALDX
$351M
| – | – |
-200,000
| Closed | -$800K |
|
|
31
Avalo Therapeutics
AVTX
$122M
| – | – |
-1,510,095
| Closed | -$2.57M |
|